发明名称 Quinoline derivatives as inhibitors of MEK enzymes.
摘要 A compound of formula (I)or a pharmaceutically acceptable salt thereof; for use as a medicament wherein:n is 0-1;Y is selected from -NH-, -O-, -S-, or -NR<7>- where R<7 >is alkyl of 1-6 carbon atomsR<5 >is chloro or bromo;Y is selected from -NH-, -O-, -S-, or -NR<7>- where R<7 >is alkyl of 1-6 carbon atomsR<6 >is a specified cyclic group which may be substituted by various specified substituents,or R<6 >is a group -R<8>-X-R<9 >whereR<8 >is selected from various cycloalkyl, pyridinyl, pyimidinyl, or phenyl ring; any of which may be optionally subsituted as described,where X is selected from CH2, -NH-, -O-, -S-, CH2 or -NR<5>- where R<5 >is alkyl of 1-6 carbon atoms, and R<9 >is a group (CH2)mR<10 >where m is 0, or an integer of from 1-3 and R<10 >is an optionally substituted aryl or optionally substituted cycloalkyl ring of up to 10 carbon atoms,or R<10 >is a heterocyclic ring containing 1 or 2 oxygen atoms and optionally one or more substitutents; and R<1>, R<2>, R<3 >and R<4 >are each independently selected from hydrogen or various specified organic groups. Novel compounds are also described. The compounds are particularly useful in the inhibition of MEK enzymes.
申请公布号 ZA200108965(B) 申请公布日期 2003.01.30
申请号 ZA20010008965 申请日期 2001.10.30
申请人 ASTRAZENECA AB. 发明人 KEITH HOPKINSON GIBSON
分类号 A61K31/4706;A61K31/4709;A61P3/00;A61P35/00;A61P43/00;C07D215/44;C07D215/48;C07D401/12 主分类号 A61K31/4706
代理机构 代理人
主权项
地址